22:01 , May 30, 2019 |  BC Extra  |  Company News

Management tracks: Sanofi hires Atara's Berger; plus Emmaus, enGene and more

Two days after Atara Biotherapeutics Inc. (NASDAQ:ATRA) announced Dietmar Berger was departing as global head of R&D, Sanofi (Euronext:SAN; NASDAQ:SNY) has announced he will oversee its clinical portfolio as head of development. Prior to his...
07:00 , Sep 16, 2016 |  BC Extra  |  Company News

Management tracks

EMA said Head of International Affairs Emer Cooke will leave the agency to join the World Health Organization as head of regulation of medicines and other health technologies in WHO's essential medicines and health products...
07:00 , Jul 18, 2016 |  BC Week In Review  |  Company News

Serendex, Savara deal

Savara acquired fellow pulmonary company Serendex in a stock deal. Savara will gain Molgradex , a nebulized form of recombinant human GM-CSF that is in Phase II/III testing to treat autoimmune pulmonary alveolar proteinosis; and...
08:00 , Feb 16, 2015 |  BC Week In Review  |  Company News

CMC Biologics A/S, Serendex deal

CMC granted Serendex exclusive, worldwide rights to develop and commercialize Factor VIIa for pulmonary administration. Serendex said it plans to begin clinical trials to treat diffuse alveolar hemorrhage next year. The companies declined to disclose...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Company News

Integrated Diagnostics management update

Integrated Diagnostics Inc. , Seattle, Wash.   Business: Diagnostic   Hired: Douglas Sanders as CFO, formerly CFO of CMC Biologics A/S  ...
07:00 , May 26, 2014 |  BC Week In Review  |  Company News

Symphogen management update

Symphogen A/S , Copenhagen, Denmark   Business: Cancer, Hematology, Infectious   Hired: Mads Laustsen as chief manufacturing officer, a newly created position, effective June 1, formerly CEO of CMC Biologics A/S  ...
08:00 , Feb 3, 2014 |  BC Week In Review  |  Company News

Karolinska Development management update

Karolinska Development AB (SSE:KDEV), Solna, Sweden   Business: Cancer, Infectious, Genitourinary   Hired: Christian Tange as CFO, formerly CFO of CMC Biologics A/S , effective March 1; he succeeds Robin Wright, who is departing  ...
08:00 , Dec 16, 2013 |  BC Week In Review  |  Company News

CMC Biologics A/S, ExpreS2ion, University of Copenhagen deal

CMC said earlier this year it partnered with the university and will provide process development expertise and cGMP clinical production of the university's variant surface antigen 2 chondroitin sulphate A (VAR2CSA) antigen to develop a...
07:00 , Aug 6, 2012 |  BC Week In Review  |  Company News

CMC Biologics A/S, Xoma deal

Contract manufacturing organization CMC Biologics will sublease Xoma's 31,000 square foot manufacturing facility equipped for biological manufacturing in Berkeley, Calif., and will purchase certain manufacturing assets no longer required by Xoma. CMC expects to begin...
08:00 , Dec 10, 2007 |  BC Week In Review  |  Company News

CMC Biopharmaceuticals A/S, Eli Lilly deal

Contract development and manufacturing company CMC will acquire LLY's biologics manufacturing facility in Bothell, Wash. for an undisclosed sum. The facility came from Icos Corp. , which LLY acquired in January (see BioCentury, Oct. 23,...